Vaginal News and Research

RSS

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

"Results of a major HIV prevention trial suggest that daily use of a product -- whether a vaginal gel or an oral tablet -- does not appear to be the right approach for preventing HIV in young, unmarried African women," a press release from the Microbicide Trials Network reports.

6 Mar 2013

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.

6 Mar 2013

Forceps delivery ‘does not increase atopy risk’

Results from a population-based cohort study suggest that forceps-assisted birth is associated with an increased risk for asthma, but not allergic sensitization, in later childhood.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

WomanCare Global, Evofem enter strategic alliance

Evofem announced today that it has entered into a strategic alliance with WomanCare Global. Through this alliance, WomanCare Global will provide sales, marketing and global distribution for a selection of Evofem's products, including Softcup and Amphora.

4 Mar 2013

Macrophages allow entry of HIV in the urethra

Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.

1 Mar 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Surgeons told to pull the plug on robotically assisted hysterectomy

US researchers are calling for curbs on the rapidly increasing use of robotically assisted hysterectomy after an extensive study of the technique showed that it fails to improve outcomes over laparoscopy.

26 Feb 2013

Study finds sharp rise in robotically-assisted hysterectomy use for benign gynecologic disorders

Between 2007 and 2010, the use of robotically-assisted hysterectomy for benign gynecologic disorders increased substantially, although, when compared with laparoscopic hysterectomy, the robotic procedure appears to offer little short-term benefit and is accompanied by significantly greater costs, according to a study appearing in the February 20 issue of JAMA.

20 Feb 2013

Research reveals no advantage in choosing cesarean births for twin pregnancies

In a study to be presented on February 14 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest that planned birthing of twins at 32-38 weeks by cesarean section does not decrease perinatal or neonatal death compared to planned vaginal birth.

13 Feb 2013

Around-the-clock labor and delivery coverage decrease odds of cesarean delivery

In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest around-the-clock labor and delivery coverage decreased the odds of cesarean delivery.

12 Feb 2013

Long-acting reversible contraception with progestin may increase risk of type 2 diabetes in women

A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.

11 Feb 2013

Study questions high rate of cesarean deliveries in women with aneurysms

For women with aneurysms involving the brain blood vessels, pregnancy and delivery don't appear to increase the risk of aneurysm rupture, reports a paper in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

11 Feb 2013

C. albicans capable of sexual reproduction

Like many fungi and one-celled organisms, Candida albicans, a normally harmless microbe that can turn deadly, has long been thought to reproduce without sexual mating. But a new study by Professor Judith Berman and colleagues at the University of Minnesota and Tel Aviv University shows that C. albicans is capable of sexual reproduction.

31 Jan 2013

Women more likely to experience urinary and faecal incontinence, prolapse after vaginal delivery

Women are more likely to experience urinary incontinence, prolapse and faecal incontinence 20 years after one vaginal delivery rather than one caesarean section, finds new research published in a thesis from Sahlgrenska Academy, University of Gothenburg, Sweden.

31 Jan 2013

VRAM flap success for dorsal vaginal and perineal reconstruction

Reconstruction of the dorsal vagina or perineum using the vertical rectus abdominus myocutaneous flap following extensive surgery and intraoperative radiotherapy for rectal cancer results in favorable surgical and quality of life outcomes, research shows.

25 Jan 2013

Study to determine prevalence of abnormal anal cytology and HPV in at-risk women

A basic connection of statistics lead a researcher at Women & Infants Hospital of Rhode Island to question whether women should be screened for anal cancer during a regular visit to the gynecologist, and what technique is most effective.

18 Jan 2013

Caesarean section increases risk of persistent pelvic girdle pain compared with vaginal delivery

Caesarean section increases the risk of persistent pelvic girdle pain after delivery compared with vaginal delivery, according to a new study from the Norwegian Institute of Public Health.

17 Jan 2013

Sexual dysfunction not determined by hysterectomy technique

The prevalence of hypoactive sexual desire disorder after hysterectomy does not vary with the surgical technique used, researchers report.

15 Jan 2013

FDA clears Hologic's APTIMA Trichomonas vaginalis Assay

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has cleared for marketing its APTIMA Trichomonas vaginalis Assay on the Company's fully-automated PANTHER System.

From Hologic, Inc. 15 Jan 2013